Award winning executive search to the private, and investor backed health, care, and life sciences sectors

Trusted executive search partner to the investment community delivering outstanding leaders for the healthcare and life sciences sectors

Mandates delivered to date

0 %

Delivery rate of all retained mandates

0 %

C-suite appointments are women

0 +

Sub-sectors in healthcare and life sciences supported

Healthcare news, data and analysis
Via Investors in Healthcare

Czechia-based Zentiva, a European generics pharmaceutical company, has changed hands between Advent and GTCR – two global PE firms. The sale – for a reported €4.1bn (US$4.8bn) – comes almost […]

Czechia: Advent sells European generics pharma, Zentiva, to GTCR

September 12, 2025

Buy Out Debt M&A Manufacturing – Generics News

Nasdaq-listed GE HealthCare is to acquire icometrix, a Belgium-based company focused on providing AI-powered brain imaging analysis for neurological disorders. The acquisition addresses the growing demand for more frequent neurological […]

Belgium: GE HealthCare strengthening neurology portfolio with acquisition of icometrix

September 11, 2025

Life Sciences M&A Medtech – Healthcare IT News Belgium

TVM Capital Healthcare, a global private equity investor and operator specialised in healthcare growth capital across emerging markets, has announced the first close of its US$150m TVM Healthcare Southeast Asia […]

Singapore: TVM’s first close of Southeast Asia Fund anchored by Invest International

September 11, 2025

Buy Out News Venture Eelco Benink Hoda Abou-Jamra

Symeres, a Netherlands-headquartered mid-sized transatlantic CRDMO, has acquired DGr Pharma, a Netherlands-based drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate IND-enabling capabilities for biopharma clients. […]

The Netherlands: Symeres enhances regulatory expertise and broadens biopharma capabilities with acquisition of DGr Pharma

September 10, 2025

Buy Out M&A News Pharma Services – CRO/CMO/CDMO

Christoph Braks has joined 4P Capital, a Germany-based commercial impact asset manager, as a partner, to launch and lead the Private Equity practice. “Why 4P? We’re hunting for alpha where […]

Germany: Christoph Braks joins 4P Capital to launch and lead PE practice

September 10, 2025

Education Healthcare News People Christoph Braks

Global insurer Allianz Partners has appointed Okan Özdemir as its new Chief Officer for Health and board member, effective 1 September, reporting directly to Allianz Partners CEO Tomas Kunzmann. He […]

France: Allianz Partners appoints Okan Özdemir as its new Chief Officer for Health

September 10, 2025

Healthcare Insurance News People Allianz Partners

Global law firm Goodwin has advised Eurazeo as mandated lead arranger on new refinancing and add-on acquisition facilities for United Therapy Group, a portfolio company of funds advised by Quadriga […]

Germany: Goodwin advises Eurazeo on refinancing and add-on acquisition financing for United Therapy

September 10, 2025

Consumer Healthcare Healthcare News Eurazeo Folko Moroni

Switzerland-based multinational pharmaceutical company Novartis is acquiring Nasdaq-listed Tourmaline Bio, a US-based clinical-stage biopharmaceutical company focused on developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease. Holders […]

Switzerland: Novartis to acquire Tourmaline Bio for US$1.4bn

September 9, 2025

M&A Manufacturing – Specialty Pharma News Pharma Cooley

Belgium-based A.forall, a pharmaceutical group that distributes EU-sourced pharmaceuticals to wholesalers and hospitals, has acquired Provepharm’s US generics portfolio. Provepharm is a France-based independent, international specialty pharmaceutical company. The transaction […]

Belgium: A.forall acquires Provepharm’s US generics portfolio

September 9, 2025

M&A Manufacturing – Generics News Pharma A.forall

US investment bank Stifel has announced that Jean-Baptiste Didier, a specialist in healthcare investment banking, has joined the team in its Paris office as a managing director. He will work closely with healthcare teams […]

France: Jean-Baptiste Didier joins Stifel from Citi to support European healthcare capabilities

September 9, 2025

Healthcare Life Sciences News People Pharma

Global private equity healthcare specialist Archimed has expanded Consumer Health presence with the acquisition of Groupe Laboratoire Rivadis, a France-based developer of baby and elderly skincare products. A family business, […]

France: Archimed expands Consumer Health presence with acquisition of Rivadis

September 9, 2025

Buy Out Consumer Healthcare Healthcare M&A News

Fresenius, a Germany-based global healthcare company, is receiving a new €400m (US$470m) loan from the European Investment Bank (EIB) to strengthen Fresenius’ European R&D activities. “Our mission at Fresenius is […]

Germany: Fresenius receives €400m loan from EIB to strengthen resilience of pharmaceutical production in the EU

September 8, 2025

Debt Manufacturing – Generics News Pharma EIB

NRG Therapeutics, a neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, has closed an oversubscribed £50m (US$67m) Series B financing that will enable the firm to achieve clinical […]

UK: NRG Therapeutics announces oversubscribed £50m Series B

September 8, 2025

Life Sciences News Pharma Venture British Business Bank

One of the world’s largest infrastructure asset managers, Australia-based Macquarie Asset Management, via Macquarie European Infrastructure Fund 7, has agreed to acquire a 40% stake in Portuguese healthcare group Luz […]

Portugal: Macquarie Asset Management stake in Luz Saúde values healthcare group at €1.1bn

September 8, 2025

Care Homes Healthcare Hospitals and Clinics M&A News

France-based SGD Pharma, a PAI Partners portfolio company providing pharmaceutical glass packaging, has acquired Italy-based Alphial, a producer of tubular vials and ampoules, from Italian PE firm Entangled Capital and […]

Italy: SGD Pharma reinforces tubular glass manufacturing presence with Alphial acquisition

September 8, 2025

Buy Out M&A News Pharma Services – CRO/CMO/CDMO

Compass Recruitment Solutions (CRS), a UK-based recruiter in health, care, education and life sciences has enhanced its life sciences recruitment focus with the acquisition of Leeds-based Consult Search & Selection […]

UK: CRS acquires Consult to accelerate growth in life sciences recruitment and executive search

September 8, 2025

Education Healthcare Life Sciences News People

Italian law firm BonelliErede has appointed Giuseppe Aminzade as of head of Regulatory Life Sciences, based in Milan, confirming its commitment to strengthening its leadership in one of the global […]

Italy: BonelliErede strengthens Healthcare & Life Sciences focus team with appointment of Giuseppe Aminzade

September 4, 2025

Healthcare Legal Life Sciences People Andrea Carta Mantiglia

In July, UK-based CRO Evestia Clinical acquired Atlantic Research Group (ARG), a US-based CRO, to create a global specialist CRO group. The merger expands Evestia Clinical’s global footprint in the […]

UK: Kester Capital-backed Evestia Clinical acquires ARG as next step in creation of global CRO

September 4, 2025

Buy Out M&A News Pharma Services – CRO/CMO/CDMO

Denmark-based Abacus Medicine, one of Europe’s leading parallel traders of medicine, is to acquire the Retail and Hospital (R&H) division of global specialty pharma group A.forall, a portfolio company of […]

Belgium: Abacus Medicine acquiring A.forall’s R&H division

September 4, 2025

Distribution Healthcare M&A News A.forall

Northern Horizon, a specialist social infrastructure asset manager in the Nordics, has received new equity commitments of €220m (US$256m) for its latest fund, Aged Care Social Infrastructure Fund (ACSIF), The […]

Denmark: Northern Horizon raises further €220m for ACSIF

September 4, 2025

Care Homes News Real Estate Social Care Andrew Smith

Ampersand Capital Partners, a global private equity firm specialising in life sciences and healthcare growth investments, has opened a new office in London. The move strengthens the firm’s European footprint, building […]

UK: Ampersand expands global presence with new London office and key appointments

September 4, 2025

Life Sciences News People Pharma Ampersand Capital Partners

Gilde Healthcare has appointed Dr Christian Stark as CEO of its medical technology group, which includes two manufacturers of surgical instruments in Germany: Koscher & Würtz and Christian Diener. In […]

Germany: Gilde Healthcare appoints Christian Stark as group CEO of its medical technology group

September 3, 2025

Life Sciences Medtech – Hospital Equipment News People Pharma

France-based SeqOne, a European provider of AI-powered software for next-generation sequencing (NGS) data analysis, is paying an undisclosed amount to acquire Congenica, the UK company spun out of the Wellcome Sanger […]

UK: SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine

September 3, 2025

Digital Health/Healthtech Healthcare Life Sciences M&A News

Italy-based Fidia Farmaceutici, a multinational developer company specialising in the development, manufacturing and marketing of products across joint, skin, eye, specialty and health and wellness care, has acquired Altacor, a UK-based specialist ophthalmology […]

UK: Fidia Farmaceutici enters UK market with acquisition of Altacor

September 3, 2025

Healthcare M&A News Ophthalmology Altacor

Quasar Medical, a Singapore-headquartered manufacturer of interventional and minimally invasive medical devices, has completed its acquisition of Nasdaq-listed Nordson Corporation’s design & development contract manufacturing businesses in Galway, Ireland, and […]

Singapore: Quasar Medical strengthens CDMO platform with Nordson Medical’s Ireland and Mexico facilities

September 2, 2025

M&A News Alex Wallstein Aviel Bohnik Nordson Corporation

Our Sectors

We are experts at what we do

Healthcare

Social Care

Biopharmaceuticals

Medical Technologies

Enabling Services

01 Our People

A dedicated team of executive search experts, delivering for you

The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.

Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.

Our Team

Meet the Team

Adam Carter

Meet the Team

Luke Osborne

Meet the Team

Abigail Badà

Meet the Team

Sam Leighton-Smith BA Hons

02 Expertise

Unearthing rare talent, that drive successful exits

Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.

Expertise

Board

Expertise

Executive Leadership

Expertise

Finance & Commercial

Expertise

Corporate Services

03 Our Approach

Tailoring our offering,
to provide a bespoke service

Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.

Our Approach

A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors

What our clients say

“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”

Outcomes First Group – Chair

“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”

Hengrui Therapeutics – VP, Head Biological Drug Discovery

“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”

The Professional Footballers Association (PFA) – Chief Executive Officer

“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”

Priory Group – Chief Executive Officer

“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”

Priory – Independent Non-Executive Director

“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”

AniCura – Group Chief Operating Officer

“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building. Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”

Renaiss Health – Chief Executive Officer

“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”

One Nucleus – Director

“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”

Melrose Education – Chair & CEO

“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”

Schoen Clinic – Member of Group Executive